AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · IEX Real-Time Price · USD
9.48
-0.21 (-2.17%)
At close: May 31, 2024, 4:00 PM
9.30
-0.18 (-1.90%)
After-hours: May 31, 2024, 6:36 PM EDT
AdaptHealth Market Cap
AdaptHealth has a market cap or net worth of $1.26 billion as of May 31, 2024. Its market cap has decreased by -13.97% in one year.
Market Cap
1.26B
Enterprise Value
3.53B
1-Year Change
-13.97%
Ranking
Category
Stock Price
$9.48
Market Cap Chart
Since February 16, 2018, AdaptHealth's market cap has increased from $312.50M to $1.26B, an increase of 304.08%. That is a compound annual growth rate of 24.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 31, 2024 | 1.26B | -2.16% |
| May 30, 2024 | 1.29B | -3.01% |
| May 29, 2024 | 1.33B | -1.19% |
| May 28, 2024 | 1.35B | 0.40% |
| May 24, 2024 | 1.34B | 4.67% |
| May 23, 2024 | 1.28B | -1.03% |
| May 22, 2024 | 1.29B | -0.42% |
| May 21, 2024 | 1.30B | -1.31% |
| May 20, 2024 | 1.32B | -0.90% |
| May 17, 2024 | 1.33B | 1.33% |
| May 16, 2024 | 1.31B | 0.10% |
| May 15, 2024 | 1.31B | 0.10% |
| May 14, 2024 | 1.31B | 3.48% |
| May 13, 2024 | 1.27B | -1.76% |
| May 10, 2024 | 1.29B | 5.23% |
| May 9, 2024 | 1.22B | -5.16% |
| May 8, 2024 | 1.29B | -0.72% |
| May 7, 2024 | 1.30B | -7.72% |
| May 6, 2024 | 1.41B | 3.31% |
| May 3, 2024 | 1.36B | -0.87% |
| May 2, 2024 | 1.38B | 2.89% |
| May 1, 2024 | 1.34B | 2.13% |
| Apr 30, 2024 | 1.31B | -2.76% |
| Apr 29, 2024 | 1.35B | 1.70% |
| Apr 26, 2024 | 1.32B | 3.97% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Owens & Minor | 1.33B |
| BioCryst Pharmaceuticals | 1.33B |
| Akero Therapeutics | 1.30B |
| Brookdale Senior Living | 1.30B |
| MannKind | 1.27B |
| Tarsus Pharmaceuticals | 1.25B |
| 4D Molecular Therapeutics | 1.24B |
| Ginkgo Bioworks Holdings | 1.17B |